Harrow Health Inc logo

HROW

Harrow Health Inc

$8.31

Earnings Summary

Revenue
$22.12Mn
Net Profits
$-2.44Mn
Net Profit Margins
-11.02%

Highlights

Revenue:

Harrow Health Inc’s revenue jumped 43.24% since last year same period to $22.12Mn in the Q1 2022. On a quarterly growth basis, Harrow Health Inc has generated 9.57% jump in its revenue since last 3-months.

Net Profits:

Harrow Health Inc’s net profit fell -1223.5% since last year same period to $-2.44Mn in the Q1 2022. On a quarterly growth basis, Harrow Health Inc has generated 67.13% jump in its net profits since last 3-months.

Net Profit Margins:

Harrow Health Inc’s net profit margin fell -884.37% since last year same period to -11.02% in the Q1 2022. On a quarterly growth basis, Harrow Health Inc has generated 70% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Harrow Health Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.01
EPS Estimate Current Year
-0.01

Highlights

EPS Estimate Current Quarter:

Harrow Health Inc’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a 75% jump from last quarter’s estimates.

EPS Estimate Current Year:

Harrow Health Inc’s earning per share (EPS) estimates for the current year stand at -0.01.

Key Ratios

Key ratios of the Harrow Health Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.09
Return on Assets (ROA)
0
Return on Equity (ROE)
-1.73
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Harrow Health Inc’s earning per share (EPS) fell -1000% since last year same period to -0.09 in the Q1 2022. This indicates that the Harrow Health Inc has generated -1000% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Harrow Health Inc’s return on assets (ROA) stands at 0.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Harrow Health Inc’s return on equity (ROE) stands at -1.73.

Dividend Per Share (DPS):

Harrow Health Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-05
-0.04
-0.09
-125%

Company Information

Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics, and Melt Pharmaceuticals. The Company also owns royalty rights in four clinical-stage drug candidates being developed by Surface and Melt. Supported by dedicated employees, Harrow intends to create, invest in and grow paradigm shifting healthcare businesses that put patients first.

Organisation
Harrow Health Inc
Headquarters
102 Woodmont Boulevard, Nashville, TN, United States, 37205
Employees
125
Industry
Health Technology